![Douglas Carr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Carr
Finanzdirektor/CFO bei
CENTURY THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.06.2026
Profil
Douglas Carr currently works at Heritage Conservancy, as Director, Century Therapeutics, Inc., as Chief Financial Officer & Secretary from 2025, and Novira Therapeutics, Inc., as Vice President-Finance from 2018.
Mr. Carr also formerly worked at Zocor Ltd., as Business Director-Franchise Division, Merck & Co., Inc., as Controller-Pediatric Vaccines Franchise, Omthera Pharmaceuticals, Inc., as Financial Controller, and Century Therapeutics, Inc., as Vice President-Finance & Operations.
Mr. Carr received his undergraduate degree from Rutgers State University of New Jersey.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 505’094 ( 0.28% ) | 1 Mio $ | 30.06.2026 |
Aktive Positionen von Douglas Carr
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Finanzdirektor/CFO | 11.07.2025 |
Novira Therapeutics, Inc. | Corporate Officer/Principal | 01.10.2018 |
Heritage Conservancy
 Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Douglas Carr
| Unternehmen | Position | Ende |
|---|---|---|
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Finanzdirektor/CFO | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Zocor Ltd. | Corporate Officer/Principal | - |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Comptroller/Controller/Auditor | - |
Ausbildung von Douglas Carr
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zocor Ltd. | |
Heritage Conservancy
Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Commercial Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Novira Therapeutics, Inc. | Electronic Technology |
